Research Article
SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients
Table 1
Demographic, underlying condition, treatment, chest CT scan findings, and outcomes of COVID-19 patients (n = 58).
| Data | N (%) |
| Age | Min | 21 | Max | 87 | Mean | 49.36 |
| Gender | Male | 28 (51.7) | Female | 30 (48.3) |
| Underlying condition | Heart disease | 1 (1.7) | Lung disease | 1 (1.7) | Diabetes | 4 [6] | Immunosuppressive medicine application | 1 (1.7) | Hypertension | 2 (3.4) | Hypertension + heart disease + diabetes | 1 (1.7) | Hypertension + diabetes | 1 (1.7) | Heart disease + diabetes | 1 (1.7) |
| Patients’ outcome | In ward | 32(55%) | Outpatients | 21(36%) | ICU | 5(9%) | Oxygen therapy | 30(51.7) | Ventilation | 3(5.2) | Discharge | 57 | Death | 1 |
| Treatment | Antibiotics | 55 (94.8) | Chloroquine | 21 (36.2) | Chloroquine + kaletra | 18 [31] | Chloroquine + Atazanavir | 12 (20.6) | Chloroquine + kaletra + Ribavirin | 5 (8.6) | Kaletra | 2 (3.4) |
| Chest CT scan | Yes | 52 (89.7) | No | 6 [11] | Normal | 8 (15.4) | Abnormal | 44 (84.6) |
|
|